GOLDSTEIN DOV A MD

Insider

Chief Financial Officer

Trades at: BIOA· COYA· GANX· NBSE

30D 90D 1Y

Net shares · 365d

-27.0K

0 buy · 27.0K sell

Net value · 365d

-$531.8K

$0 in · $531.8K out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 27.0K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

BIOA Exercise·M
Apr 23, 26

Chief Financial Officer

$0

3.5K sh

Own +2%
BIOA Exercise·M
Apr 23, 26

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +11%
BIOA Exercise·M
Mar 1, 26

Chief Financial Officer

$0

3.5K sh

Own +2%
BIOA Exercise·M
Mar 1, 26

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +12%
BIOA Grant·A
Feb 17, 26

Chief Financial Officer

$0

110.0K sh

Own New
BIOA Exercise·M
Feb 1, 26

Chief Financial Officer

$0

3.5K sh

Own +2%
BIOA Exercise·M
Feb 1, 26

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +14%
BIOA Exercise·M
Jan 16, 26

Chief Financial Officer

$0

3.5K sh

Own +2%
BIOA Exercise·M
Jan 16, 26

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +16%
BIOA Exercise·M
Jan 13, 26

Chief Financial Officer · 10b5-1

$0

27.0K sh

Own +41%
BIOA Exercise·M
Jan 13, 26

Chief Financial Officer · 10b5-1

$226.5K

27.0K sh · $8.39

Own +120%
BIOA Sell·S
Jan 13, 26

Chief Financial Officer · 10b5-1

$531.8K

27.0K sh · $19.70 avg · 4 lots

Own -40%
COYA Grant·A
Jan 2, 26

Director

$0

10.0K sh

Own New
COYA Exercise·M
Aug 18, 25

Director

$0

17.6K sh

Own New
COYA Exercise·M
Aug 18, 25

Director

$19.1K

17.6K sh · $1.09

Own +176%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Apr 23, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Apr 23, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+11%	$4.38	$15.5K
Mar 1, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Mar 1, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+12%	$4.38	$15.5K
Feb 17, 2026	BIOA	Chief Financial Officer	Grant A	110.0K	New	—	$0
Feb 1, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Feb 1, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+14%	$4.38	$15.5K
Jan 16, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Jan 16, 2026	BIOA	Chief Financial Officer	Exercise M	3.5K	+16%	$4.38	$15.5K
Jan 13, 2026	BIOA	Chief Financial Officer	Exercise M	27.0K	+41%	—	$0
Jan 13, 2026	BIOA	Chief Financial Officer	Exercise M	27.0K	+120%	$8.39	$226.5K
Jan 13, 2026	BIOA	Chief Financial Officer	Sell S	27.0K4 lots	-40%	$19.70 avg	$531.8K
Jan 2, 2026	COYA	Director	Grant A	10.0K	New	—	$0
Aug 18, 2025	COYA	Director	Exercise M	17.6K	New	—	$0
Aug 18, 2025	COYA	Director	Exercise M	17.6K	+176%	$1.09	$19.1K

Buy Sell Non-market (grant · exercise · gift)

About GOLDSTEIN DOV A MD

This profile aggregates every SEC Form 4 insider transaction reported by GOLDSTEIN DOV A MD across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.